Weill Cornell Medicine physician-scientist Dr. David Lyden, whose research has led to groundbreaking discoveries about how cancer spreads, has been elected into the esteemed Association of American Physicians.
Dr. Virginia Pascual has been awarded a grant supplement from the National Institute of Allergy and Infectious Diseases (NIAID) to lead a multi-institutional effort studying differences in immune responses in children infected with SARS-CoV-2.
Dr. Stanley Plotkin, the inventor of the rubella vaccine now in standard use worldwide, and pediatric physician-scientists Dr. Stephen Patrick and Dr. Sallie Permar, who research health conditions that affect newborns, were the featured speakers at a symposium held online on Oct. 20 by Weill Cornell Medicine’s Gale and Ira Drukier Institute for Children's Health.
Abnormal immune activity in lupus, a chronic disease that can cause rashes, fatigue, joint pain, and kidney failure, seems to occur mostly in small subsets of immune cells in patients, potentially enabling better targeting for future treatments, according to a study from scientists at Weill Cornell Medicine and The Jackson Laboratory for Genomic Medicine.
Tiny packets called extracellular vesicles and particles (EVPs), released by cancer and immune cells, contain specific proteins that may serve as reliable biomarkers for diagnosing early-stage cancer, according to investigators at Weill Cornell Medicine and Memorial Sloan Kettering.
Dr. Sallie Permar, a physician-scientist who investigates the prevention and treatment of neonatal viral infections, and Dr. Stephen Patrick, a neonatologist focused on the impact of the opioid epidemic on pregnant women and infants, have been jointly awarded the fifth annual Gale and Ira Drukier Prize in Children’s Health Research.
A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases.
Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to establish an Autoimmunity Center of Excellence dedicated to understanding the mechanisms that contribute to autoimmune diseases in children.Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to establish an Autoimmunity Center of Excellence dedicated to understanding the mechanisms that contribute to autoimmune diseases in children.
Weill Cornell Medicine has experienced dynamic growth in its research enterprise over the past five years, an achievement that underscores the institution’s mission to provide patients with the most advanced treatments and therapies.
Dr. Helen Su, a clinical immunologist who has made key discoveries into the genetic causes of rare immune system diseases in children, has been awarded the fourth annual Gale and Ira Drukier Prize in Children’s Health Research.
A previously unknown type of T lymphocyte, a class of white blood cell, contributes to the development of an autoimmune disease, called lupus, which causes the immune system to attack healthy tissues and organs and leads to chronic inflammation, according to a study led by Weill Cornell Medicine researchers.
Weill Cornell Medicine investigators Dr. David Lyden and Dr. Ari Melnick have been awarded Outstanding Investigator Awards from the National Cancer Institute.
Dr. Vijay Sankaran, a physician-scientist who investigates the molecular underpinnings of pediatric genetic blood disorders, has been awarded the third annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today.
A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body’s intercellular delivery service to spread to new locations in the body.
